GH1 and chronic kidney disease: Mean circulating human GH was not different between GH-treated CKD (325.3 ± 65.3 μg/L) and GH-treated control mice (364.6 ± 76.4 μg/L), whereas no human GH was detected in CKD or control mice receiving vehicle.